Trial Profile
Metabolic effects of muraglitazar in type 2 diabetic subjects.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2011
Price :
$35
*
At a glance
- Drugs Muraglitazar (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 01 Oct 2011 Results published in the Diabetes, Obesity and Metabolism.
- 05 Nov 2010 New trial record.